Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 5:35 pm Sale | 2025-12-31 | 13G | Mereo BioPharma Group plc MREO | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -32,430,690 (Position Closed) | Filing History |
| 2026-02-13 5:34 pm Purchase | 2025-12-31 | 13G | Aura Biosciences, Inc. AURA | Frazier Life Sciences Public Fund, L.P. | 4,032,060 6.300% | 918,510 (+29.50%) | Filing History |
| 2026-02-13 5:33 pm Purchase | 2025-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Frazier Life Sciences Public Fund, L.P. | 3,698,271 5.100% | 624,804 (+20.33%) | Filing History |
| 2026-02-13 5:33 pm Purchase | 2025-12-31 | 13G | Palvella Therapeutics, Inc. PVLA | Frazier Life Sciences Public Fund, L.P. | 706,360 6.000% | 160,856 (+29.49%) | Filing History |
| 2026-02-13 5:31 pm Sale | 2025-12-31 | 13G | Xilio Therapeutics, Inc. XLO | Frazier Life Sciences Public Fund, L.P. | 4,676,472 6.700% | -3,464,545 (-42.56%) | Filing History |
| 2026-02-13 5:31 pm Purchase | 2025-12-31 | 13G | Maze Therapeutics, Inc. MAZE | Frazier Life Sciences Public Fund, L.P. | 4,342,266 9.000% | 989,351 (+29.51%) | Filing History |
| 2026-02-13 5:30 pm Purchase | 2025-12-31 | 13G | Savara Inc. SVRA | Frazier Life Sciences Public Fund, L.P. | 8,343,048 4.100% | 1,597,752 (+23.69%) | Filing History |
| 2026-02-13 5:29 pm Sale | 2025-12-31 | 13G | MacroGenics, Inc. MGNX | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -1,549,193 (Position Closed) | Filing History |
| 2025-12-19 4:40 pm Purchase | 2025-12-18 | 13G | Vor Biopharma Inc. VOR | Frazier Life Sciences Public Fund, L.P. | 2,258,001 5.800% | 2,258,001 (New Position) | Filing History |
| 2025-12-16 4:39 pm Purchase | 2025-12-09 | 13G | iBio, Inc. IBIO | Frazier Life Sciences Public Fund, L.P. | 1,953,467 8.700% | 1,953,467 (New Position) | Filing History |
| 2025-12-09 5:31 pm Sale | 2025-12-09 | 13G | Adverum Biotechnologies, Inc. ADVM | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -4,288,949 (Position Closed) | Filing History |
| 2025-11-28 3:25 pm Purchase | 2025-11-25 | 13G | Adverum Biotechnologies, Inc. ADVM | Frazier Life Sciences Public Fund, L.P. | 4,288,949 19.400% | 3,159,892 (+279.87%) | Filing History |
| 2025-11-14 4:29 pm Sale | 2025-09-30 | 13G | Trevi Therapeutics, Inc. TRVI | Frazier Life Sciences Public Fund, L.P. | 8,508,021 7.000% | -1,751,388 (-17.07%) | Filing History |
| 2025-11-14 4:28 pm Purchase | 2025-09-30 | 13G | Jade Biosciences, Inc. JBIO | Frazier Life Sciences Public Fund, L.P. | 1,384,646 4.200% | 43,943 (+3.28%) | Filing History |
| 2025-11-04 5:24 pm Unchanged | 2025-11-01 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 5,985,327 8.600% | 0 (Unchanged) | Filing History |
| 2025-11-04 5:21 pm Purchase | 2025-11-01 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 3,466,521 6.900% | 1,066,245 (+44.42%) | Filing History |
| 2025-09-30 5:01 pm Purchase | 2025-09-26 | 13D | MBX Biosciences, Inc. Common Stock MBX | Frazier Life Sciences Public Fund, L.P. | 5,224,095 11.700% | 666,998 (+14.64%) | Filing History |
| 2025-09-17 5:21 pm Sale | 2025-09-17 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -10,639,562 (Position Closed) | Filing History |
| 2025-08-20 5:23 pm Sale | 2025-08-18 | 13D | MBX Biosciences, Inc. Common Stock MBX | Frazier Life Sciences Public Fund, L.P. | 4,557,097 13.600% | -1,428,250 (-23.86%) | Filing History |
| 2025-08-20 5:20 pm Sale | 2025-08-18 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 2,400,276 4.800% | -2,487,591 (-50.89%) | Filing History |